Porcine Vaccine Market by Product and Geography - Forecast and Analysis 2022-2026

The porcine vaccine market share is expected to increase by USD 794.67 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.01%.

This porcine vaccine market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers porcine vaccine market segmentations by product (intravenous, intramuscular, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The porcine vaccine market report also offers information on several market vendors, including Bimeda Inc., Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., FATRO SpA, Formosa Biomedical Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Phibro Animal Health Corp., Veterinary Provisions Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc. among others.

What will the Porcine Vaccine Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Porcine Vaccine Market Size for the Forecast Period and Other Important Statistics

 

Porcine Vaccine Market: Key Drivers, Trends, and Challenges

The increasing prevalence of porcine diseases is notably driving the porcine vaccine market growth, although factors such as lack of trained veterinary doctors may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the porcine vaccine industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Porcine Vaccine Market Driver

The increasing prevalence of porcine diseases is one of the key drivers supporting the porcine vaccine market growth. Porcine vaccines have potential usage in the treatment and management of various epidemic porcine diseases such as PRRS, porcine circovirus-associated disease (PCVAD), and other target diseases. The increasing prevalence of such porcine diseases will lead to an increased demand for inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, and other porcine vaccines during the forecast period. PRRS is a viral-borne disease in swine, characterized by reproductive impairment or failure in nursing swine and respiratory disease in pigs of any age. The disease can lead to reproductive failure, pneumonia, and increased susceptibility to secondary bacterial infection. such increasing diseases will drive the porcine vaccine market growth during the forecast period.

Key Porcine Vaccine Market Trend

Strategic initiatives by market vendors is one of the key porcine vaccine market trends that is contributing to the market growth. Vendors invest in developing innovative products and launching new porcine vaccines to increase their foothold in the market. Moreover, intense competition in the market is expected to compel the established vendors to increase their market presence through partnerships and strategic alliances. Market vendors such as Boehringer Ingelheim International GmbH (Boehringer Ingelheim) and Zoetis Inc. are focusing on strategic expansion of their business portfolios to broaden their geographic reach and meet the growing demand for porcine vaccines. The key strategies used by these market vendors focus on the expansion of their facilities, M&A, and partnerships. Such strategic initiatives will propel the porcine vaccine market growth during the forecast period.

Key Porcine Vaccine Market Challenge

The lack of trained veterinary doctors is one of the factors hindering the porcine vaccine market growth. The lack of highly skilled professionals with the clinical and analytical knowledge required to perform swine disease detection tests and interpret the results negatively impacts the adoption and use of porcine vaccines. Moreover, the decrease in the number of educational programs on epidemic porcine diseases that are offered to veterinary students, the presence of inadequate facilities in veterinary centers, and the lack of veterinary hospitals and clinics in emerging economies lead to a lack of awareness about porcine diseases and vaccines. These factors will have a negative impact on the growth of the global porcine vaccine market during the forecast period.

This porcine vaccine market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global porcine vaccine market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the porcine vaccine market during the forecast period.

Who are the Major Porcine Vaccine Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Bimeda Inc.
• Bioveta AS
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Elanco Animal Health Inc.
• FATRO SpA
• Formosa Biomedical Inc.
• LABORATORIOS HIPRA SA
• Merck and Co. Inc.
• Phibro Animal Health Corp.
• Veterinary Provisions Inc.
• Vetoquinol SA
• Virbac Group
• Zoetis Inc.

 

This statistical study of the porcine vaccine market encompasses successful business strategies deployed by the key vendors. The porcine vaccine market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

• Bioveta AS - Through the human health segment, the company offers various pharmaceuticals products for human health. 
• Bioveta AS - The company offers porcine vaccine such as ERYSIN SINGLE SHOT. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The porcine vaccine market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Porcine Vaccine Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the porcine vaccine market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Porcine Vaccine Market?

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the porcine vaccine market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The rising animal healthcare expenditure will facilitate the porcine vaccine market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic had a negative impact on the regional porcine vaccine market. However, in 2021, due to the availability of COVID-19 vaccines, the number of COVID-19 cases in the region declined. Thus, due to the ease of COVID-related restrictions and with access to veterinary clinics being restored, the demand for porcine vaccines rebounded. Thus, due to these factors, the regional porcine market will have a positive impact during the forecast period.

What are the Revenue-generating Product Segments in the Porcine Vaccine Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The porcine vaccine market share growth by the intravenous segment will be significant during the forecast period. Healthy swine production requires various injections which can help provide pigs with vaccines, antibiotics, and others. However, proper injection techniques must be followed in order to minimize pain at the site of injection and avoid the accumulation of illegal residues in pigs. Thus, specific and approved routes of drug administration must be followed to provide maximum results. The routes of administration for porcine vaccines include intravenous (IV) and intramuscular (IM), among others. Vendors in the market offer inactivated vaccines, live attenuated vaccines, toxoid vaccines, and recombinant vaccines, which can be administered intravenously. Thus, the availability of a wide range of porcine vaccines which can be administered intravenously will drive the growth of the global porcine vaccine during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the porcine vaccine market size and actionable market insights on post COVID-19 impact on each segment.

 

Porcine Vaccine Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 7.01%
Market growth 2022-2026	$ 794.67 million
Market structure	Concentrated
YoY growth (%)	6.2
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 42%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Bimeda Inc., Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., FATRO SpA, Formosa Biomedical Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Phibro Animal Health Corp., Veterinary Provisions Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Porcine Vaccine Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive porcine vaccine market growth during the next five years
• Precise estimation of the porcine vaccine market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the porcine vaccine industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of porcine vaccine market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch